Mallory Loflin
Mallory Loflin
VA Center of Excellence for Stress and Mental Health
Verified email at va.gov
Title
Cited by
Cited by
Year
Labeling accuracy of cannabidiol extracts sold online
MO Bonn-Miller, MJE Loflin, BF Thomas, JP Marcu, T Hyke, R Vandrey
Jama 318 (17), 1708-1709, 2017
2492017
A New Method of Cannabis Ingestion: The Dangers of Dabs?
M Loflin, M Earleywine
Addictive Behaviors, 2014
1732014
Cannabinoids as therapeutic for PTSD
M Loflin, K Babson, M Bonn-Miller
Current Opinion in Psychology 14, 78-83, 2017
382017
Subtypes of attention deficit-hyperactivity disorder (ADHD) and cannabis use
M Loflin, M Earleywine, J De Leo, A Hobkirk
Substance use & misuse 49 (4), 427-434, 2014
312014
Medicinal versus recreational cannabis use: Patterns of cannabis use, alcohol use, and cued-arousal among veterans who screen positive for PTSD
M Loflin, M Earleywine, M Bonn-Miller
Addictive Behaviors, 2017
242017
No smoke, no fire: what the initial literature suggests regarding vapourized cannabis and respiratory risk
M Loflin, M Earleywine
Canadian Journal of Respiratory Therapy: CJRT= Revue Canadienne de la …, 2015
232015
Cannabis and cannabinoid drug development: evaluating botanical versus single molecule approaches
MO Bonn-Miller, MA ElSohly, MJE Loflin, S Chandra, R Vandrey
International Review of Psychiatry 30 (3), 277-284, 2018
192018
Assessment of the validity of the CUDIT-R in a subpopulation of cannabis users
M Loflin, K Babson, K Browne, M Bonn-Miller
The American journal of drug and alcohol abuse 44 (1), 19-23, 2018
142018
Don’t wake and bake: morning use predicts cannabis problems
M Earleywine, R Luba, MN Slavin, S Farmer, M Loflin
Addiction Research & Theory 24 (5), 426-430, 2016
92016
Curious Consequences of Cannabis Prohibition
M Earleywine, M Loflin
Alb. Gov't L. Rev. 6, 438-663, 2013
62013
The state of clinical outcome assessments for cannabis use disorder clinical trials: A review and research agenda
MJE Loflin, BD Kiluk, MA Huestis, WM Aklin, AJ Budney, KM Carroll, ...
Drug and alcohol dependence, 107993, 2020
42020
Placebo effects of edible cannabis: Reported intoxication effects at a 30-minute delay
MJE Loflin, M Earleywine, S Farmer, M Slavin, R Luba, M Bonn-Miller
Journal of Psychoactive Drugs 49 (5), 393-397, 2017
32017
The case for medical marijuana: an issue of relief.
M Loflin, M Earleywine
Drug and alcohol dependence 149, 293, 2015
32015
A cross-sectional examination of choice and behavior of veterans with access to free medicinal cannabis
MJE Loflin, K Babson, J Sottile, SB Norman, S Gruber, MO Bonn-Miller
The American journal of drug and alcohol abuse 45 (5), 506-513, 2019
22019
Navigating Blind in the Green Rush: Clinical Considerations and Harm Reduction Practices for Cannabis
BN Meffert, DM Morabito, MK Mosich, MJ Loflin, J Sottile, AJ Heinz
Current Drug Research Reviews Formerly: Current Drug Abuse Reviews 11 (1), 3-11, 2019
22019
Do I smell pot? A trial of an alternative paradigm of olfactory cue-reactance to marijuana
MJ Loflin, M Earleywine
Addiction Research & Theory 22 (3), 210-217, 2014
22014
A Cross-Sectional and Prospective Comparison of Medicinal Cannabis Users and Controls on Self-Reported Health
NJ Schlienz, R Scalsky, EL Martin, H Jackson, J Munson, JC Strickland, ...
Cannabis and Cannabinoid Research, 2020
12020
Aversiveness and Meaningfulness of Uncomfortable Experiences with Edible Cannabis
S Farmer, MN Slavin, MJE Loflin, R Luba, M Earleywine
Journal of psychoactive drugs 51 (5), 413-420, 2019
12019
Craving and Cannabis: A Potential Paradox
MJ Loflin, M Earleywine
Handbook of Cannabis and Related Pathologies, 317-325, 2017
12017
Burden of cannabis use and disorder in the US veteran population: psychiatric comorbidity, suicidality, and service utilization
ML Hill, BM Nichter, SB Norman, M Loflin, RH Pietrzak
Journal of affective disorders, 2020
2020
The system can't perform the operation now. Try again later.
Articles 1–20